Photo from wikipedia
Jiasheng Wang , Srilatha Dasari, Dina Elantably, Akram Alkrekshi and Yeseong David Kim Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Department… Click to show full abstract
Jiasheng Wang , Srilatha Dasari, Dina Elantably, Akram Alkrekshi and Yeseong David Kim Department of Hematology and Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Department of Internal Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA; Section of Gastroenterology, Department of Medicine, Temple University, Philadelphia, PA, USA
Keywords:
inhibitors patients;
end stage;
patients end;
stage renal;
use inhibitors;
medicine
Journal Title: Acta Oncologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Oncologica
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!